Pharma company Sandoz named in US price-fixing lawsuit
Sandoz split from Novartis in 2003 and now has annual sales in excess of $10 billion.
Keystone / Martin Ruetschi
The Germany-based subsidiary of Swiss pharmaceutical giant Novartis is one of 20 companies in the United States targeted in a 44-state class action suit for breaching rules on fair competition.
This content was published on
1 minute
SDA-Keystone/ac
The names of the companies were revealed on SundayExternal link by Connecticut Attorney General William Tong. The lawsuit accuses the companies of inflating the prices of more than 100 different drugs.
“Sandoz’s name appears in a court case, which concerns virtually the entire pharmaceutical generics industry,” Novartis told the Swiss news agency AWP. According to the Basel-based parent company, the accusations are unfounded and will be contested vigorously.
The American prosecutor mentioned that “Teva, Sandoz, Mylan, Pfizer and 16 other generic producers” are accused of conspiring among themselves to set prices, allocate markets and distort offers of more than 100 generic products. In some cases, the price of some substances increased more than tenfold. In addition to Sandoz, a former vice president at the company, Armando Kellum, was named as an individual defendant in the case.
“We have hard evidence that shows the generic drug industry perpetrated a multi-billion-dollar fraud on the American people,” said Tong. “We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
This content was published on
On Saturday the Lake Geneva, Valais and Basel regions are expected to record the first tropical day of the year, with temperatures exceeding 30°C.
This content was published on
The Swiss economy saw the clouds that had gathered over its prospects lift somewhat in May. However, the KOF economic barometer is still below its long-term average.
Direct operations too dangerous in Swiss landslide valley
This content was published on
By Friday morning 365 people had been forced to leave their homes because of Wednesday's landslide in the Swiss village of Blatten.
Franco-Swiss raclette war set to be settled on Sunday
This content was published on
The battle for the world's largest raclette will be transformed on Sunday in Saint-Gingolph, canton Valais, into a raclette of friendship served at the border.
Flood risk threatens Swiss valley after ‘millennium event’ glacier collapse
This content was published on
Two days after a gigantic avalanche of ice, mud and debris buried much of the village of Blatten in canton Valais, the danger is not over.
Situation in Swiss landslide valley remains unstable
This content was published on
Authorities in Valais said on Thursday that it was still too dangerous to begin clear-up activities around the village of Blatten.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.